$REE

REE Automotive (REE) details CBO Miller’s RSUs, options and shares

REE Automotive filed an amended insider ownership report (Form 3/A) detailing the equity holdings of its Chief Business Officer, Tali Miller. The report outlines her restricted stock units (RSUs) across various grants, stock options with a specified exercise price, and directly held Class A Ordinary Shares. It also includes vesting schedules for RSUs, indicating future share entitlements, and notes that options were granted pre-IPO and are fully vested.

Original reporting
Published Mar 19, 2026, 9:40 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Mar 19, 2026, 10:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$REE
Neutral
medium confidence
Mentioned
$REE
Relevance
6/10
AlphAI data visualization · based on Stock Titan
Decision brief

The 30-second read

$REENeutralLow
01

Why it matters

The insider's holdings suggest confidence but are not sufficient alone to influence trading decisions.

02

Market read

The news has limited immediate impact on REE's stock or the broader market but may be of interest to long-term investors monitoring insider confidence.

03

What to watch

The filing does not specify the company's current stock price, recent performance, or market conditions, which are critical for comprehensive analysis.

Relevance 6/10Timing: short-term

Background

REE Automotive is an electric vehicle technology company with recent filings indicating insider holdings.

Company-level read

Ticker impact

$REENeutralMedium confidence
Context

The news pertains to insider holdings of REE Automotive's Chief Business Officer, which could influence perceptions of company management and future performance.

Expected impact

Minimal immediate impact; potential long-term positive if insider holdings are viewed as confidence in company prospects.

Evidence & confidence

While insider holdings can signal confidence, the overall impact on stock price is limited without additional context such as recent price movements or market conditions.

Market effects

Limited; the news is specific to insider holdings and does not indicate sector-wide changes.

Negligible; no regional effects are implied.

Negligible; the news is company-specific.

Counterpoint

Insider holdings might be used to mask internal concerns or upcoming dilution events; thus, the insider's interests may not always align with shareholder value.

Key entities

  • Tali Miller

    Chief Business Officer of REE Automotive.

  • REE Automotive

    Electric vehicle technology manufacturer.

Related articles

$CEROHighAI 8/10

Delisting of Securities from The Nasdaq Stock Market

Nasdaq said it will delist multiple issuers’ securities from the Nasdaq Stock Market, including CERo Therapeutics Holdings, Bowen Acquisition Corp, Graphjet Technology, Blue Hat Interactive Entertainment Technology, X3 Holdings Co, Captivision Inc, Actelis Networks, American Rebel Holdings, Reviva Pharmaceuticals, Alchemy Investments Acquisition Corp 1, Bitcoin Depot, Inotiv, GoHealth, Functional Brands, Sleep Number, Smart Digital Group, and REE Automotive. Most were suspended in 2025-2026 and

$FWRDMed

Forward Air Announces Two-Year Definitive Agreement to Retain Significant Portion of Previously Disclosed Customer Relationship

FORWARD AIR CORP (FWRD) filed an SEC Form 8-K — Other Events. Forward Air Announces Two-Year Definitive Agreement to Retain Significant Portion of Previously Disclosed Customer Relationship 2026 to 2028 Forecasted Annual Revenue from Customer Expected to Exceed 2025 Revenue Driven by Growth in Retained Services DALLAS – October 28, 2026 – F

$PYPDMedAI 8/10

PolyPid unveils PD01B for diabetic foot infection treatment

PolyPid Ltd. (NASDAQ:PYPD) introduced PD01B, a product candidate for treating moderate to severe diabetic foot infections, using its Kynatrix delivery technology. The company plans to initiate a first-in-human study in the second half of 2027. PolyPid also expects a decision on its lead product D-PLEX₁₀₀ by November 28, 2026, with a potential U.S. launch in early 2027, subject to FDA approval.

$KTOSMed

Kratos wins $33.6 million NASA power system contract

Kratos Defense & Security Solutions (KTOS) won a $33.6M contract from NASA to design and build a power system for the Space Reactor-1 Freedom spacecraft, launching in 2028. Kratos will work as a subcontractor to Sierra Lobo under NASA’s SpaceDOC III contract, providing a power conversion system for the mission to Mars. The spacecraft aims to demonstrate nuclear electric propulsion technology. According to the company, the contract is a significant milestone in advancing space nuclear propulsion.